- Research Article
The effects of markedly raised intracellular sphingosine kinase-1 activity in endothelial cells
Cellular & Molecular Biology Letters volume 14, pages 411–423 (2009)
The enzyme sphingosine kinase-1 (SK1) promotes the formation of sphingosine-1-phosphate (S1P), which is an important survival factor for endothelial cells (EC). Modest increases in intracellular SK1 activity in the EC are known to confer a survival advantage upon the cells. Here, we investigated the effects of more dramatic increases in intracellular SK1 in the EC. We found that these cells show reduced cell survival under conditions of stress, enhanced caspase-3 activity, cell cycle inhibition, and cell-cell junction disruption. We propose that alterations in the phosphorylation state of the enzyme may explain the differential effects on the phenotype with modest versus high levels of enforced expression of SK1. Our results suggest that SK1 activity is subject to control in the EC, and that this control may be lost in conditions involving vascular regression.
human umbilical vein endothelial cell
platelet-endothelial cell adhesion molecule-1
sphingosine kinase-1 (SK1)
tumour necrosis factor
Kwon, Y.G., Min, J.K., Kim, K.M., Lee, D.J., Billiar, T.R. and Kim, Y.M. Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J. Biol. Chem. 276 (2001) 10627–10633.
Wang, F., Van Brocklyn, J.R., Hobson, J.P., Movafagh, S., Zukowska-Grojec, Z., Milstien, S. and Spiegel, S. Sphingosine 1-phosphate stimulates cell migration through a G(i)- coupled cell surface receptor. Potential involvement in angiogenesis. J. Biol. Chem. 274 (1999) 35343–35350.
Lee, M.J., Van Brocklyn, J.R., Thangada, S., Liu, C.H., Hand, A.R., Menzeleev, R., Spiegel, S. and Hla, T. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279 (1998) 1552–1555.
Ghosh, T.K., Bian, J. and Gill, D.L. Intracellular calcium release mediated by sphingosine derivatives generated in cells. Science 248 (1990) 1653–1656.
Desai, N.N., Zhang, H., Olivera, A., Mattie, M.E. and Spiegel, S. Sphingosine-1-phosphate, a metabolite of sphingosine, increases phosphatidic acid levels by phospholipase D activation. J. Biol. Chem. 267 (1992) 23122–23128.
Limaye, V., Li, X., Hahn, C., Xia, P., Berndt, M.C., Vadas, M.A. and Gamble, J.R. Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members. Blood. 105 (2005) 3169–3177.
Evans, P.C., Taylor, E.R. and Kilshaw, P.J. Signaling through CD31 protects endothelial cells from apoptosis. Transplantation 71 (2001) 457–460.
Xia, P., Gamble, J.R., Wang, L., Pitson, S.M., Moretti, P.A., Wattenberg, B.W., D’Andrea, R.J. and Vadas, M.A. An oncogenic role of sphingosine kinase. Curr. Biol. 10 (2000) 1527–1530.
Cramer, E.M., Berger, G. and Berndt, M.C. Platelet-granule and plasma membrane share two components: CD9 and PECAM-1. Blood 84 (1994) 1722–1730.
Litwin, M., Clark, K., Noack, L., Furze, J., Berndt, M., Albelda, S., Vadas, M., and Gamble, J.R. Novel cytokine-independent induction of endothelial adhesion molecules regulated by platelet/endothelial cell adhesion molecule (CD31). J. Cell. Biol. 139 (1997) 219–228.
Pitson, S.M., Moretti, P.A.B., Zebol, J.R., Lynn, H.E., Xia, P., Vadas, M.A., Wattenberg, B.W. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 22 (2003) 5491–5500.
Xia, P., Gamble, J.R., Rye, K.A., Wang, L., Hii, C.S., Cockerill, P., Khew-Goodall, Y., Bert, A.G., Barter, P.J., and Vadas, M.A. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc. Natl. Acad. Sci. USA 95 (1998) 14196–14201.
Spiegel, S., Olivera, A., Zhang, H., Thompson, E.W., Su, Y. and Berger, A. Sphingosine-1-phosphate, a novel second messenger involved in cell growth regulation and signal transduction, affects growth and invasiveness of human breast cancer cells. Breast Cancer Res. Treat. 31 (1994) 337–348.
Pitson, S.M., Moretti, P.A., Zebol, J.R., Xia, P., Gamble, J.R., Vadas, M.A., D’Andrea, R.J. and Wattenberg, B.W. Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation. A dominant-negative sphingosine kinase. J. Biol. Chem. 275 (2000) 33945–33950.
Limaye, V., Xia, P., Hahn, C., Smith, M., Vadas, M.A, Pitson, S.M. and Gamble, J.R. Chronic increases in sphingosine kinase-1 activity induce a pro-inflammatory, pro-angiogenic phenotype in endothelial cells. Cell. Mol. Biol. Lett. 14 (2009) in press, DOI: 10.2478/s11658-009-0009-1.
About this article
Cite this article
Limaye, V., Vadas, M.A., Pitson, S.M. et al. The effects of markedly raised intracellular sphingosine kinase-1 activity in endothelial cells. Cell Mol Biol Lett 14, 411–423 (2009). https://doi.org/10.2478/s11658-009-0008-2
- Sphingosine kinase-1
- Endothelial cells
- Cell survival